Pace® Life Sciences Expands Biologics Development, Manufacturing, and Analytical Testing Capabilities for 2025
Company Enhances Sterile Fill-Finish Services and Increases Capacity to Support Biologics and Gene Therapy Development
MINNEAPOLIS (FreePR.org) -- Pace® Life Sciences, LLC, a leading U.S.-based contract research, development, and manufacturing organization (CRDMO) and a division of Pace®, is proud to announce significant expansions at its Salem, NH, and Oakdale, MN, facilities. These developments are set to increase capacity for biologics development, manufacturing, and analytical testing, meeting the growing demands of the pharmaceutical and biopharmaceutical industries.
Pace® Life Sciences partners with pharma and biopharma manufacturers to advance programs from early research and development through clinical trials and commercialization. The planned facility upgrades will add sterile fill-finish capabilities and advanced analytical support for biologics, gene therapies, and other innovative molecules. “These expansions enable us to accelerate clinical trial material development and better serve underserved markets,” said Frank Tagliaferri, Chief Science Officer at Pace® Life Sciences.
Oakdale, MN: Expanded Testing and Job Creation
The Oakdale site, which received a 2024 grant from Minnesota’s Department of Employment and Economic Development (DEED), is undergoing an 8,000-square-foot expansion. This growth will include state-of-the-art facilities for testing drugs in the commercial phase and the creation of over 50 new jobs. Key enhancements include a dedicated RNase-free environment and expanded cell-based assay capabilities, supporting both widely distributed therapeutics and treatments for rare diseases.
Salem, NH: Center of Excellence for Sterile Fill-Finish
The Salem facility is on track to be classified as a Center of Excellence (CoE) for sterile fill-finish processing. The addition of an isolated vial-filling line ensures compliance with EU Annex 1 standards, offering the highest level of sterility assurance. “This expansion allows us to deliver world-class cGMP manufacturing services for vaccines, gene therapies, antibodies, and protein-based therapeutics,” added Tagliaferri.
Commitment to Innovation and Growth
Pace® Life Sciences continues to expand its capabilities through strategic acquisitions and investments. In 2024, the company added its Research Triangle Park, NC, location, enhancing expertise in Container Closure Integrity Testing (CCIT), and acquired a Lebanon, NJ, site to broaden service offerings. “We are dedicated to supporting our clients’ critical, life-saving work by continuously improving and investing in our facilities and expertise,” said Dawn Von Rohr, President of Pace® Life Sciences.
About Pace® Life Sciences
Pace® Life Sciences delivers comprehensive contract CMC development, clinical trial material manufacturing, regulatory compliance, and facility support services to pharmaceutical, biopharmaceutical, and gene therapy industries. With a network of GMP analytical testing labs and manufacturing support centers, Pace® combines cutting-edge facilities with experienced professionals to help clients efficiently advance programs from the clinic to commercialization. For more information, visit PACELIFESCIENCES.com.
About Pace®
Pace® is a portfolio company of Leonard Green & Partners and Aurora Capital Partners, committed to advancing innovation and improving patient lives.
###
Contact Information:
Pam Bednar
Marketing Director
pam.bednar@pacelabs.com
612-297-0651
Brooke Schwartzel
Brand & Communications Manager
brooke.schwartzel@pacelabs.com
612-656-2241
Sponsor Message
Affordable prescriptions for essential drugs like Lipitor, Crestor, and Nexium make Canadian pharmacies a popular choice for millions of Americans. Canadian pharmacies provide vital medications for chronic conditions, including Humalog and Lantus for diabetes and Advair Diskus and Ventolin inhalers for respiratory issues. Medications such as Zoloft, Prozac, and Abilify help with mental health disorders, while blood thinners like Eliquis, Plavix, and Xarelto provide crucial stroke prevention. Pain relief and inflammation management are addressed with medications like Celebrex, while thyroid issues are treated with popular therapies such as Synthroid. Furthermore, popular medications like Viagra and Cialis provide relief for erectile dysfunction, while Januvia helps regulate diabetes. Wakefulness-promoting medications like Provigil and Nuvigil are essential for maintaining alertness in those with narcolepsy. Canadian pharmacies improve the lives of American patients by providing affordable medications such as Cymbalta for nerve pain and Aricept for Alzheimer's.
